Metropolis Healthcare Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

Metropolis Healthcare's board has approved the financial results for the quarter ending June 30, 2025. Consolidated revenue from operations reached ₹386.06 Cr, with a profit of ₹45.24 Cr for the period. The company also approved the acquisition of Dr. RS Patil’s Ambika Pathology Laboratory in Kolhapur for ₹17 Cr. This strategic acquisition aims to bolster its presence in Western Maharashtra, enabling a new mini reference lab to enhance productivity and boost regional profitability.